Senate, June 5, 2014 -- The committee on Ways and Means, to whom was referred the House Bill relative to the substitution of interchangeable biosimilars (House, No. 3734); reports, recommending that the same ought to pass with an amendment striking out all after the enacting clause and inserting in place thereof the text of Senate document numbered 2176 and by striking out the title and inserting in place thereof the following title: “An Act relative to the substitution of biosimilars.”
No amendments have been filed against the Engrossed Bill.
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.